Tech Company Financing Transactions
DiaMonTech Funding Round
DiaMonTech closed a $7.7 million Series A venture capital round on 9/9/2019. Investors included BioVentures Investors and IBB Ventures.
Transaction Overview
Company Name
Announced On
9/9/2019
Transaction Type
Venture Equity
Amount
$7,700,000
Round
Series A
Investors
BioVentures Investors (Lead Investor) (Erik Hoppe)
IBB Ventures (Christian Seegers)
Proceeds Purpose
DiaMonTech intends to use the new financing to further develop and optimise its non-invasive blood glucose monitoring technologies.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Boxhagener Str. 82 A
Berlin, 10245
Germany
Berlin, 10245
Germany
Phone
Website
Email Address
Overview
DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thorsten Lubinski
Chief Financial Officer
Martin Jakob
Chief Operating Officer
Sergius Janik
Chief Scientific Officer
Werner Mäntele
VP - Bus. Development
Markus Teuber
VP - General Counsel
Rainer Gith
Browse more venture capital transactions:
Prev: 9/9/2019: Ori venture capital transaction
Next: 9/9/2019: Health Recovery Solutions venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs